Key result
Intensified extrarenal replacement therapy is associated with ~57% complete resolution of uremic pericarditis.
Why the study?
Uremic pericarditis is a late complication of CKD, and this study aimed to describe its risk factors and outcomes in patients with chronic kidney failure at Donka University Hospital.
Cross-Sectional (n=182)
No
Answers are grounded in this paper and cite their sources.
Uremic pericarditis remains a frequent complication in hemodialysis patients in Guinea, strongly associated with inadequate dialysis and highlighting the need for optimized renal replacement therapy.
Introduction: Uremic pericarditis is a late complication of chronic kidney disease (CKD), often latently detected by echocardiography or clinically revealed by chest pain and a pericardial rub. The objective of our study was to describe the risk factors and outcome of uremic pericarditis in patients with chronic kidney failure at the Donka University Hospital. Methods: This was a cross-sectional, descriptive and analytical study conducted over a 7-month period from August 10 to March 10, 2022. All patients with a GFR ≤ 60 ml/min were included. The parameters studied were: epidemiological, clinical, and ultrasound. The Chi-square test was used for statistical analysis. Results: In 182 chronic uremic patients, uremic pericarditis was 12.63%. Pericardial friction rub was present to varying degrees in 91.30% of cases; the average clearance was 4.39. Pericarditis was observed on ultrasound in 82.60% of cases. The risk factors identified were: young age and terminal stage. All of our patients received extrarenal replacement therapy (ERP) and NSAIDs. Intensified EER resulted in complete resolution of pericarditis in 56.5%; surgical drainage in 4.4%, and 39.1% died. Conclusion: The prevalence of uremic pericarditis is relatively high. Early diagnosis and management could improve life expectancy.
No takes yet. Share an insight, caveat, or question.
Diakité et al. (2026) conducted a cross-sectional in Chronic hemodialysis patients with chronic kidney failure and uremic pericarditis at Donka University Hospital (n=182). Intensified extrarenal replacement therapy (ERP) plus NSAIDs was evaluated on Resolution of uremic pericarditis and mortality. Intensified extrarenal replacement therapy led to complete resolution of uremic pericarditis in 56.5% of patients, with 39.1% mortality among chronic kidney failure patients at Donka University Hospital.
Synapse has enriched 10 related papers. Consider them for comparative context: